ASX - By Stock
|
DXB |
Re:
Ann: Dimerix and Taiba enter into License Agreement for DMX-200
|
|
Paralogical
|
152 |
58K |
0 |
28/05/24 |
28/05/24 |
ASX - By Stock
|
152
|
58K
|
0
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
Paralogical
|
510 |
117K |
6 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
510
|
117K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Board Changes
|
|
Paralogical
|
250 |
62K |
11 |
09/05/24 |
09/05/24 |
ASX - By Stock
|
250
|
62K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
Paralogical
|
261 |
71K |
8 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
261
|
71K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Mainstream media is GO
|
|
Paralogical
|
31 |
11K |
36 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
31
|
11K
|
36
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Great Pharmaust FDA ODD Approval Sweepstake
|
|
Paralogical
|
222 |
47K |
4 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
222
|
47K
|
4
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Great Pharmaust FDA ODD Approval Sweepstake
|
|
Paralogical
|
222 |
47K |
5 |
18/03/24 |
18/03/24 |
ASX - By Stock
|
222
|
47K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Big Pharma buyouts.
|
|
Paralogical
|
39 |
9.5K |
4 |
12/03/24 |
12/03/24 |
ASX - By Stock
|
39
|
9.5K
|
4
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Trading Halt
|
|
Paralogical
|
247 |
78K |
33 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
247
|
78K
|
33
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Application for quotation of securities - PAA
|
|
Paralogical
|
77 |
20K |
7 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
77
|
20K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Application for quotation of securities - PAA
|
|
Paralogical
|
77 |
20K |
5 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
77
|
20K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
Paralogical
|
317 |
82K |
15 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
317
|
82K
|
15
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
Paralogical
|
317 |
82K |
26 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
317
|
82K
|
26
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Paralogical
|
1.4K |
359K |
12 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
1.4K
|
359K
|
12
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
Paralogical
|
317 |
82K |
5 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
317
|
82K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Positive Phase 1 MEND Study Top-Line Results
|
|
Paralogical
|
152 |
47K |
5 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
152
|
47K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Positive Phase 1 MEND Study Top-Line Results
|
|
Paralogical
|
152 |
47K |
12 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
152
|
47K
|
12
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Positive Phase 1 MEND Study Top-Line Results
|
|
Paralogical
|
152 |
47K |
8 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
152
|
47K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Positive Phase 1 MEND Study Top-Line Results
|
|
Paralogical
|
152 |
47K |
2 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
152
|
47K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Positive Phase 1 MEND Study Top-Line Results
|
|
Paralogical
|
152 |
47K |
9 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
152
|
47K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Investor webinar - Phase 1 MND Study Top-Line Results
|
|
Paralogical
|
209 |
50K |
15 |
26/02/24 |
26/02/24 |
ASX - By Stock
|
209
|
50K
|
15
|
|
ASX - By Stock
|
PAA |
Re:
Ann: FDA Provides Clear Feedback for ODD Approval
|
|
Paralogical
|
323 |
76K |
14 |
04/02/24 |
04/02/24 |
ASX - By Stock
|
323
|
76K
|
14
|
|
ASX - By Stock
|
PAA |
Re:
Ann: FDA Provides Clear Feedback for ODD Approval
|
|
Paralogical
|
323 |
76K |
12 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
323
|
76K
|
12
|
|
ASX - By Stock
|
PAA |
Re:
Ann: FDA Provides Clear Feedback for ODD Approval
|
|
Paralogical
|
323 |
76K |
16 |
29/01/24 |
29/01/24 |
ASX - By Stock
|
323
|
76K
|
16
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust Launches Interactive Investor Hub
|
|
Paralogical
|
16 |
3.3K |
5 |
18/12/23 |
18/12/23 |
ASX - By Stock
|
16
|
3.3K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust Raises $3.5 Million at a Premium
|
|
Paralogical
|
60 |
14K |
13 |
13/12/23 |
13/12/23 |
ASX - By Stock
|
60
|
14K
|
13
|
|
ASX - By Stock
|
PAA |
Re:
Ann: New Hires & Attendance at International MND Symposium
|
|
Paralogical
|
56 |
13K |
14 |
07/12/23 |
07/12/23 |
ASX - By Stock
|
56
|
13K
|
14
|
|
ASX - By Stock
|
PAA |
Re:
PHARMAUST MND UPDATE!!!!! Swallow and Walk!!!!
|
|
Paralogical
|
40 |
8.7K |
10 |
28/11/23 |
28/11/23 |
ASX - By Stock
|
40
|
8.7K
|
10
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Link for the Monsoon Twilight Briefing
|
|
Paralogical
|
18 |
3.8K |
12 |
24/11/23 |
24/11/23 |
ASX - By Stock
|
18
|
3.8K
|
12
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: US Medicare confirms reimbursement price for PromarkerD
|
|
Paralogical
|
14 |
3.7K |
4 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
14
|
3.7K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Questions for the AGM
|
|
Paralogical
|
19 |
3.9K |
13 |
13/11/23 |
13/11/23 |
ASX - By Stock
|
19
|
3.9K
|
13
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust to present at Emerging ASX Gems Conference
|
|
Paralogical
|
82 |
18K |
21 |
03/11/23 |
03/11/23 |
ASX - By Stock
|
82
|
18K
|
21
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 4C and Quarterly Update
|
|
Paralogical
|
83 |
15K |
9 |
31/10/23 |
31/10/23 |
ASX - By Stock
|
83
|
15K
|
9
|
|
ASX - By Stock
|
PAA Biotech |
Re:
FDA Application for Orphan Drug Designation , PAA, MPL
|
|
Paralogical
|
355 |
69K |
3 |
21/10/23 |
21/10/23 |
ASX - By Stock
|
355
|
69K
|
3
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Proteomics International Webinar and Q&A
|
|
Paralogical
|
19 |
5.6K |
1 |
04/10/23 |
04/10/23 |
ASX - By Stock
|
19
|
5.6K
|
1
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, The New Dawn, September , Optober 2023
|
|
Paralogical
|
132 |
33K |
14 |
19/09/23 |
19/09/23 |
ASX - By Stock
|
132
|
33K
|
14
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: New oesophageal cancer test presented at global conference
|
|
Paralogical
|
6 |
2.3K |
8 |
09/09/23 |
09/09/23 |
ASX - By Stock
|
6
|
2.3K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Chief Executive Officer Appointment
|
|
Paralogical
|
95 |
23K |
32 |
01/09/23 |
01/09/23 |
ASX - By Stock
|
95
|
23K
|
32
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Chief Executive Officer Appointment
|
|
Paralogical
|
95 |
23K |
9 |
28/08/23 |
28/08/23 |
ASX - By Stock
|
95
|
23K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Chief Executive Officer Appointment
|
|
Paralogical
|
95 |
23K |
12 |
28/08/23 |
28/08/23 |
ASX - By Stock
|
95
|
23K
|
12
|
|
ASX - By Stock
|
PAA |
Re:
Who wants a Zoom Meeting with Management
|
|
Paralogical
|
28 |
5.1K |
7 |
22/08/23 |
22/08/23 |
ASX - By Stock
|
28
|
5.1K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Additional Phase 1 data suggest MPL may inhibit MND
|
|
Paralogical
|
380 |
84K |
9 |
22/08/23 |
22/08/23 |
ASX - By Stock
|
380
|
84K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
Paralogical
|
78 |
21K |
14 |
22/08/23 |
22/08/23 |
ASX - By Stock
|
78
|
21K
|
14
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Cohort 3 Pharmacokinetics in MND Patients Completed
|
|
Paralogical
|
140 |
31K |
11 |
09/08/23 |
09/08/23 |
ASX - By Stock
|
140
|
31K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Epichem enters voluntary liquidation
|
|
Paralogical
|
218 |
50K |
13 |
01/08/23 |
01/08/23 |
ASX - By Stock
|
218
|
50K
|
13
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: June 2023 Quarterly Activities Report and Appendix 4C
|
|
Paralogical
|
1 |
1.1K |
5 |
24/07/23 |
24/07/23 |
ASX - By Stock
|
1
|
1.1K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Motor Neurone Disease Phase 1/2 Clinical Trial Update
|
|
Paralogical
|
165 |
35K |
13 |
24/07/23 |
24/07/23 |
ASX - By Stock
|
165
|
35K
|
13
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Promarker pipeline - Oesophageal cancer diagnostic update
|
|
Paralogical
|
2 |
1.2K |
4 |
20/07/23 |
20/07/23 |
ASX - By Stock
|
2
|
1.2K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Louie the Beagle surpasses one year on MPL
|
|
Paralogical
|
37 |
7.7K |
10 |
10/07/23 |
10/07/23 |
ASX - By Stock
|
37
|
7.7K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
Ann: MND Biomarkers and Pharmacodynamics Results
|
|
Paralogical
|
396 |
84K |
19 |
04/07/23 |
04/07/23 |
ASX - By Stock
|
396
|
84K
|
19
|
|